273 related articles for article (PubMed ID: 33176190)
1. Nanocarriers Mediated Cutaneous Drug Delivery.
Güngör S; Kahraman E
Eur J Pharm Sci; 2021 Mar; 158():105638. PubMed ID: 33176190
[TBL] [Abstract][Full Text] [Related]
2. Potential enhancement and targeting strategies of polymeric and lipid-based nanocarriers in dermal drug delivery.
Kahraman E; Güngör S; Özsoy Y
Ther Deliv; 2017 Nov; 8(11):967-985. PubMed ID: 29061106
[TBL] [Abstract][Full Text] [Related]
3. Nanocarrier-based topical drug delivery for the treatment of skin diseases.
Gupta M; Agrawal U; Vyas SP
Expert Opin Drug Deliv; 2012 Jul; 9(7):783-804. PubMed ID: 22559240
[TBL] [Abstract][Full Text] [Related]
4. Nanocarriers for drug delivery into and through the skin - Do existing technologies match clinical challenges?
Vogt A; Wischke C; Neffe AT; Ma N; Alexiev U; Lendlein A
J Control Release; 2016 Nov; 242():3-15. PubMed ID: 27449743
[TBL] [Abstract][Full Text] [Related]
5. The Factors Determining the Skin Penetration and Cellular Uptake of Nanocarriers: New Hope for Clinical Development.
Farjami A; Salatin S; Jafari S; Mahmoudian M; Jelvehgari M
Curr Pharm Des; 2021; 27(42):4315-4329. PubMed ID: 34779364
[TBL] [Abstract][Full Text] [Related]
6. Nanocarriers Mediated Topical Drug Delivery for Psoriasis Treatment.
Gungor S; Rezigue M
Curr Drug Metab; 2017; 18(5):454-468. PubMed ID: 28228078
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in follicular drug delivery of nanoparticles.
Patzelt A; Lademann J
Expert Opin Drug Deliv; 2020 Jan; 17(1):49-60. PubMed ID: 31829758
[No Abstract] [Full Text] [Related]
8. Co-Encapsulation of Drugs for Topical Application-A Review.
Ataide JA; Coco JC; Dos Santos ÉM; Beraldo-Araujo V; Silva JRA; de Castro KC; Lopes AM; Filipczak N; Yalamarty SSK; Torchilin VP; Mazzola PG
Molecules; 2023 Feb; 28(3):. PubMed ID: 36771111
[TBL] [Abstract][Full Text] [Related]
9. Skin penetration/permeation success determinants of nanocarriers: Pursuit of a perfect formulation.
Elmowafy M
Colloids Surf B Biointerfaces; 2021 Jul; 203():111748. PubMed ID: 33853001
[TBL] [Abstract][Full Text] [Related]
10. Combined use of nanocarriers and physical methods for percutaneous penetration enhancement.
Dragicevic N; Maibach H
Adv Drug Deliv Rev; 2018 Mar; 127():58-84. PubMed ID: 29425769
[TBL] [Abstract][Full Text] [Related]
11. Lipid nanocarriers as skin drug delivery systems: Properties, mechanisms of skin interactions and medical applications.
Sala M; Diab R; Elaissari A; Fessi H
Int J Pharm; 2018 Jan; 535(1-2):1-17. PubMed ID: 29111097
[TBL] [Abstract][Full Text] [Related]
12. Lipid nanoparticles for dermal drug delivery.
Kakadia PG; Conway BR
Curr Pharm Des; 2015; 21(20):2823-9. PubMed ID: 25925115
[TBL] [Abstract][Full Text] [Related]
13. Limitations and Opportunities in Topical Drug Delivery: Interaction Between Silica Nanoparticles and Skin Barrier.
Arriagada F; Morales J
Curr Pharm Des; 2019; 25(4):455-466. PubMed ID: 30947656
[TBL] [Abstract][Full Text] [Related]
14. Emerging Technologies to Target Drug Delivery to the Skin - the Role of Crystals and Carrier-Based Systems in the Case Study of Dapsone.
Schneider-Rauber G; Argenta DF; Caon T
Pharm Res; 2020 Nov; 37(12):240. PubMed ID: 33169237
[TBL] [Abstract][Full Text] [Related]
15. Nanocrystals as an emerging nanocarrier for the management of dermatological diseases.
Parveen N; Abourehab MAS; Thanikachalam PV; Khar RK; Kesharwani P
Colloids Surf B Biointerfaces; 2023 May; 225():113231. PubMed ID: 36907135
[TBL] [Abstract][Full Text] [Related]
16. Nano-Lipidic Carriers as a Tool for Drug Targeting to the Pilosebaceous Units.
Ramkar S; Sah AK; Bhuwane N; Choudhary I; Hemnani N; Suresh PK
Curr Pharm Des; 2020; 26(27):3251-3268. PubMed ID: 32410556
[TBL] [Abstract][Full Text] [Related]
17. Nanocarriers for treatment of dermatological diseases: Principle, perspective and practices.
Ramanunny AK; Wadhwa S; Gulati M; Singh SK; Kapoor B; Dureja H; Chellappan DK; Anand K; Dua K; Khursheed R; Awasthi A; Kumar R; Kaur J; Corrie L; Pandey NK
Eur J Pharmacol; 2021 Jan; 890():173691. PubMed ID: 33129787
[TBL] [Abstract][Full Text] [Related]
18. Gradient-dependent release of the model drug TRITC-dextran from FITC-labeled BSA hydrogel nanocarriers in the hair follicles of porcine ear skin.
Tran NBNN; Knorr F; Mak WC; Cheung KY; Richter H; Meinke M; Lademann J; Patzelt A
Eur J Pharm Biopharm; 2017 Jul; 116():12-16. PubMed ID: 27693856
[TBL] [Abstract][Full Text] [Related]
19. Delivery and targeting of nanoparticles into hair follicles.
Fang CL; Aljuffali IA; Li YC; Fang JY
Ther Deliv; 2014; 5(9):991-1006. PubMed ID: 25375342
[TBL] [Abstract][Full Text] [Related]
20. Interaction of nanoparticles and cell-penetrating peptides with skin for transdermal drug delivery.
Desai P; Patlolla RR; Singh M
Mol Membr Biol; 2010 Oct; 27(7):247-59. PubMed ID: 21028936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
